ASH Clinical News FINAL_ACN_3.14_FULL_ISSUE_DIGITAL | Page 140

DEEPEN YOUR KNOWLEDGE OF FLT3m+ AML AT
THE 59TH ASH ANNUAL MEETING AND EXPOSITION.
VISIT BOOTH #2007
Go to FLT3AML-revealed.com
AML=acute myeloid leukemia; ASH=American Society of Hematology;
FLT3=FMS-like tyrosine kinase 3; m+=mutation positive.
© 2017 Astellas Pharma US, Inc. All rights reserved. 077-0047-PM. 10/17
Astellas and the flying star logo are trademarks of Astellas Pharma Inc.